Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EAPM 2017 /
The Innovative Medicines Initiative

27th - 30th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.17
Views: 805
Rating:

Dr Pierre Meulien - Innovation Medicines Initiative, Brussels, Belgium

Pierre Meulien speaks to ecancer at EAPM 2017 in Belfast.

He was explaining how several projects in the IMI portfolio, (cancer, autism and asthma) were working.

This is due to the collaboration and integration pushed by the IMI

He highlights the funding and also the long term goals of the IMI. 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence